TrivarX Limited
MDBIF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 27% | -7.5% | -4.5% | – |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | 100% | -10.5% | -120.2% | 99.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -75.9% | -149.9% | -262.3% | -257% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -83.5% | -139.2% | -319.7% | -1,264.7% |
| EPS Diluted | -0.002 | -0.004 | -0.017 | -0.12 |
| % Growth | 52.5% | 76.9% | 85.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |